Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZEAL | RAPP | CSTL | ||
| Company | Zealand Pharma A/S ADR | Rapport Therapeutics Inc | Castle Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.03 | 22.33 | 28.56 | ||
| High | 18.07 | 23.44 | 29.70 | ||
| Low | 17.47 | 21.89 | 28.38 | ||
| Last | 17.59 | 22.52 | 28.88 | ||
| Change | +0.21 | +0.33 | +0.43 | ||
| % Change | +1.21% | +1.49% | +1.51% | ||
| Volume | 2,100 | 102,100 | 424,700 | ||
| 20-Day Average Volume | 2,250 | 80,015 | 470,520 | ||
| Previous Close | 17.38 | 22.19 | 28.45 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 24.07 | 31.77 | ||
| 20-Day Raw Stochastic | 27.14% | 29.72% | 19.07% | ||
| 20-Day Relative Strength | 50.34% | 48.02% | 43.88% | ||
| Weighted Alpha | -38.80 | N/A | +44.12 | ||
| Today's Opinion | 48% Buy | N/A | 56% Buy | ||
| Previous Opinion | 32% Buy | N/A | 56% Buy | ||
| Last Month's Opinion | 24% Buy | N/A | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 09/21/22 | +2.46% since 11/14/24 | -6.33% since 11/14/24 | ||
| Low | 16.54 on 09/27/22 | 20.20 on 11/15/24 | 27.24 on 11/19/24 | ||
| High | 18.07 on 09/29/22 | 23.44 on 11/21/24 | 30.63 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +2.45% since 08/29/22 | -8.90% since 10/21/24 | -9.38% since 10/21/24 | ||
| Low | 16.51 on 09/19/22 | 20.20 on 11/15/24 | 27.24 on 11/19/24 | ||
| High | 20.03 on 09/09/22 | 28.00 on 11/07/24 | 35.84 on 11/05/24 | ||
| 3-Month | |||||
| %Chg | +32.96% since 06/29/22 | +0.22% since 08/21/24 | +3.70% since 08/21/24 | ||
| Low | 12.82 on 07/01/22 | 18.01 on 09/13/24 | 26.44 on 08/22/24 | ||
| High | 20.49 on 08/25/22 | 29.74 on 10/16/24 | 35.84 on 11/05/24 | ||
| 6-Month | |||||
| %Chg | +20.23% since 03/29/22 | N/A since 06/07/24 | +15.89% since 05/21/24 | ||
| Low | 9.93 on 05/16/22 | 16.55 on 08/08/24 | 16.97 on 07/05/24 | ||
| High | 20.49 on 08/25/22 | 29.74 on 10/16/24 | 35.84 on 11/05/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 818,603 | 823,692 | 808,842 | ||
| Shares Outstanding, K | 46,538 | 36,576 | 28,007 | ||
| Annual Sales | 46,550,000 | 0 | 219,790,000 | ||
| Annual Net Income | -161,990,000 | -34,790,000 | -57,470,000 | ||
| Last Quarter Sales | 4,060,000 | 0 | 85,780,000 | ||
| Last Quarter Net Income | -69,960,000 | -17,540,000 | 2,270,000 | ||
| 60-Month Beta | 1.45 | N/A | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 08/11/22 | -0.50 on 11/07/24 | 0.08 on 11/04/24 | ||
| Latest Earnings Date | 11/10/22 | 11/14/24 | 11/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 142.25 | ||